Immunome

IMNMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.835 B

$25.03 -3.06%

Close of 7 Aug 2026

Revenue

$6.94M

#3241 by revenue

Earnings

-$212.4M

Loss-making

Shares outstanding

113,133,199

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#81Arcutis BiotherapeuticsARQT$3.18B
#82Disc MedicineIRON$2.97B
#83ImmunomeIMNM$2.83B
#84Supernus PharmaceuticalsSUPN$2.77B
#85AtaiBeckleyATAI$2.67B

Where these numbers come from

Share counts and financials for Immunome are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.